| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0029 | 1 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.0033 | 1 |
| mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |